Literature DB >> 2823826

L-652,343, a novel dual cyclo/lipoxygenase inhibitor, inhibits LTB4-production by stimulated human polymorphonuclear cells but not by stimulated human whole blood.

P Gresele1, J Arnout, H Deckmyn, J Vermylen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2823826     DOI: 10.1016/0006-2952(87)90336-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  4 in total

Review 1.  Rationally designed multitarget agents against inflammation and pain.

Authors:  S H Hwang; A T Wecksler; K Wagner; B D Hammock
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

2.  Pharmacological evidence for the existence of a local renin-angiotensin system in porcine interlobar renal arteries.

Authors:  E Müller-Schweinitzer; I Olea-Baza
Journal:  Br J Pharmacol       Date:  1990-09       Impact factor: 8.739

3.  Interaction of cyclosporine-A with the renin-angiotensin system in canine veins.

Authors:  E Müller-Schweinitzer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-08       Impact factor: 3.000

4.  Lipoxygenase inhibitory activity of U-66,858 and its deacetylated metabolite U-68,244 in human whole blood.

Authors:  J A Summers; A Bye; C Robinson
Journal:  Agents Actions       Date:  1994-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.